'Victrelis'™ Added To Peginterferon Alfa-2a And Ribavirin Gives Higher Cure Rates In Treatment-Failure Patients With Chronic HCV Genotype 1
Links shared publicly online about this topic.
- 396total visits
'Victrelis'™ Added To Peginterferon Alfa-2a And Ribavirin Gives Higher Cure Rates In Treatment-Failure Patients With Chronic HCV Genotype 1
View full resource at medicalnewstoday.com
Tags: Liver Condition, Hepatitis, Hepatitis C, Hepatitis C Medication, Rebetol, Boceprevir
Most Recently Shared on April 1, 2011 at 11:05 pm By:
'Victrelis'™ Added To Peginterferon Alfa-2a And Ribavirin Gives Higher Cure Rates In Treatment-Failure Patients ... http://mnt.to/3T54
HCV New Drug Research: EASL-Anemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-Anemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 4:12 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
EASL-Anemia Management Strategies Used With VICTRELIS® (boceprevir) Combination Therapy http://t.co/fupckHe9
HCV New Drug Research: Victrelis (boceprevir)-B.C. expands PharmaCare coverage for Hepatitis C
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Victrelis (boceprevir)-B.C. expands PharmaCare coverage for Hepatitis C” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 26, 2012 at 9:11 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
B.C. expands PharmaCare coverage for Hepatitis C http://t.co/PRrvyT5U
NICE Recommends Unrestricted Access To 'Victrelis'® (boceprevir) When Used Within The Licensed Indication
medicalnewstoday.com — “In the UK, about 216,000 people suffer from a chronic infection of hepatitis C.5. The UK's National Institute for Health and Clinical Excellence (NICE) has just issued a Final Appraisal Determinat” View full resource at medicalnewstoday.com
Most Recently Shared on March 9, 2012 at 8:39 pm By:
NICE Recommends Unrestricted Access To 'Victrelis'® (boceprevir) When Used Within The… http://t.co/aPSx4sL6
HCV New Drug Research: Victrelis-It's the first step into a new era
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Victrelis-It's the first step into a new era” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 9, 2012 at 3:00 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Victrelis-It's the first step into a new era http://t.co/0GxUWYhe
HCV New Drug Research: Victrelis-Merck's hepatitis C drug wins UK cost endorsement
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Victrelis-Merck's hepatitis C drug wins UK cost endorsement” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 9, 2012 at 3:59 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Victrelis-Merck's hepatitis C drug wins UK cost endorsement http://t.co/iZXxKVUd
HCV New Drug Research: Victrelis-Merck's hepatitis C drug wins UK cost endorsement
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Victrelis-Merck's hepatitis C drug wins UK cost endorsement” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on March 9, 2012 at 3:16 am By:
Tina Banwart - HepatitisCNewDrugs Health Blog
Victrelis-Merck's hepatitis C drug wins UK cost endorsement http://t.co/UhfxDZ6F
preview
emailactivity.ecn5.com — “preview” View full resource at emailactivity.ecn5.com
Most Recently Shared on February 13, 2012 at 1:30 pm By:
PharmaLive Health News and Pharma
#FDA, #Merck Warn #Victrelis Weakens Some HIV Drugs http://t.co/A7xwZ41m #TherapeuticsDaily
SAFETY ALERT: Drug Interactions Between Protease Inhibitors for Hepatitis C and HIV - MPR
empr.com — “The FDA has notified healthcare professionals that drug interactions between the hepatitis C virus (HCV) protease inhibitor Victrelis (boceprevir; Merck) and certain ritonavir-boosted human immunodeficiency virus (HIV) protease inhibitors can potentially reduce the effectiveness of these medicines when they are used together.” View full resource at empr.com
Most Recently Shared on February 9, 2012 at 8:20 pm By:
SAFETY ALERT: Drug Interactions Between Protease Inhibitors for #Hepatitis C and #HIV http://t.co/bC6NTI6q
Hepatitis C New Drug Research
hepatitiscnewdrugresearch.com — “Will The New HCV Drugs Have Fewer Side Effects?” View full resource at hepatitiscnewdrugresearch.com
Most Recently Shared on February 2, 2012 at 10:01 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
INCIVEK-Telaprevir and VICTRELIS-Boceprevir Side Effects http://t.co/BBxv2AhQ
HCV New Drug Research: New HCV Clinical Trial To Evaluate Merck’s-VICTRELIS with Roche's Mericitabine Plus SOC
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: New HCV Clinical Trial To Evaluate Merck’s-VICTRELIS with Roche's Mericitabine Plus SOC” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on December 16, 2011 at 10:59 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
New HCV Clinical Trial To Evaluate Merck’s-VICTRELIS with Roche's Mericitabine Plus SOC #hepatitis http://t.co/XwPBcx33
HCV New Drug Research: New HCV Clinical Trial To Evaluate Merck’s-VICTRELIS with Roche's Mericitabine Plus SOC
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: New HCV Clinical Trial To Evaluate Merck’s-VICTRELIS with Roche's Mericitabine Plus SOC” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on December 16, 2011 at 10:57 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
New HCV Clinical Trial To Evaluate Merck’s-VICTRELIS with Roche's Mericitabine Plus SOC http://t.co/FwH08jPk
Merck News Item
merck.com — “Merck News Item” View full resource at merck.com
Most Recently Shared on October 28, 2011 at 11:13 am By:
Januvia, Janumet up 40%-plus; Victrelis at $31M, $53M YTD RT @Merck: Announcing 3Q financial results. http://t.co/k1KCYZ8q $MRK #pharma
THE RPM REPORT
therpmreport.com — “THE RPM REPORT” View full resource at therpmreport.com
Most Recently Shared on October 25, 2011 at 2:43 pm By:
Ramsey Baghdadi Health Communicator
The VA's Impact on Biotech ($$): http://t.co/D1ZdkOix Hep C Victrelis, Incivek. Also Regeneron, Lucentis, Avastin.
Nuevas opciones de tratamiento en el horizonte para las personas co-infectadas con el VIH y la hepatitis C - The AIDS Beacon
aidsbeacon.com — “Según un artículo reciente, Victrelis e Incivek, dos nuevos medicamentos para el tratamiento de la hepatitis C, podrían estar disponibles ...” View full resource at aidsbeacon.com
Most Recently Shared on October 18, 2011 at 11:45 am By:
Eli Camhi Health IT and Social Worker
New treatment options on the horizon for people co-infected with HIV and hepatitis C http://t.co/q078DDQF Click the flag for English
HCV New Drug Research: AASLD-New Data Analyses for VICTRELIS™ (boceprevir) will be Presented By Merck
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: AASLD-New Data Analyses for VICTRELIS™ (boceprevir) will be Presented By Merck” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on September 30, 2011 at 4:10 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
AASLD-New Data Analyses for VICTRELIS™ (boceprevir) will be Presented By Merck http://t.co/qi3oQnjj
Advertisement
